Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Zhejiang Chemsyn Pharm CoBJSE:920656 36 Interest Coverage is 29.11 as of Mar. 2026, which is 99% below its 10-year median of 2,041.63. GuruFocus rates BJSE:920656 with a GF Score™ of 36/100. The stock has 4 warning signs investors should review. Among 15 Healthcare Plans companies, Zhejiang Chemsyn Pharm Co ranks better than 80% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Zhejiang Chemsyn Pharm Co's
Operating Income
for the
three
months ended in Mar. 2026 was ¥22.1 Mil. Zhejiang Chemsyn Pharm Co's Interest Expense for the
three
months ended in Mar. 2026 was ¥-0.8 Mil.
Zhejiang Chemsyn Pharm Co's interest coverage for the quarter that ended in Mar. 2026 was 29.11.
The higher the ratio, the stronger the company's financial strength is.
Good Sign:
Zhejiang Chemsyn Pharm Co Ltd has no debt.
The historical rank and industry rank for Zhejiang Chemsyn Pharm Co's Interest Coverage or its related term are showing as below:
BJSE:920656'
s Interest Coverage Range Over the Past 10 Years
Min: 72.38 Med: 2041.63 Max: 23601.75
Current: 74.37
BJSE:920656's Interest Coverage is ranked better than 80% of 15
companies
in the Healthcare Plans industry
Industry Median: 4.55
vs BJSE:920656: 74.37
Zhejiang Chemsyn Pharm Co (BJSE:920656) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Zhejiang Chemsyn Pharm Co Interest Coverage Related Terms
Zhejiang Chemsyn Pharm Co Interest Coverage Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
BJSE:920656 vs UNH, CVS, ELV: Interest Coverage Comparison
For the Healthcare Plans subindustry, Zhejiang Chemsyn Pharm Co's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zhejiang Chemsyn Pharm Co Interest Coverage vs Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, Zhejiang Chemsyn Pharm Co's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Zhejiang Chemsyn Pharm Co's Interest Coverage falls into.
Zhejiang Chemsyn Pharm Co Interest Coverage Calculation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zhejiang Chemsyn Pharm Co (BJSE:920656) has a Interest Coverage of 29.11 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Zhejiang Chemsyn Pharm Co and its competitors. This is 99% below median its historical median of 2,041.63. Over the past decade, Zhejiang Chemsyn Pharm Co's Interest Coverage has ranged from 72.38 to 23,601.75. According to the industry distribution chart, Zhejiang Chemsyn Pharm Co ranks #3 out of 15 companies in the Healthcare Plans industry, placing it in the top 20%.
Is Zhejiang Chemsyn Pharm Co's Interest Coverage too high?
Zhejiang Chemsyn Pharm Co's current Interest Coverage of 29.11 is 99% below median its 10-year median of 2,041.63. Over the past 10 years, this metric has ranged from a low of 72.38 to a high of 23,601.75. The Healthcare Plans industry median Interest Coverage is 4.55. Zhejiang Chemsyn Pharm Co's value of 29.11 is 539.8% above this industry median. Based on the distribution chart, Zhejiang Chemsyn Pharm Co ranks #3 out of 15 companies in the Healthcare Plans industry, which is in the top quartile — a strong position relative to peers. Overall, Zhejiang Chemsyn Pharm Co has a GF Score™ of 36/100, reflecting its overall financial health beyond just this single metric.
How does Zhejiang Chemsyn Pharm Co's Interest Coverage compare to UNH and CVS?
According to the Healthcare Plans industry distribution chart, Zhejiang Chemsyn Pharm Co ranks #3 out of 15 companies for Interest Coverage. This places Zhejiang Chemsyn Pharm Co in the top 20% of its industry — outperforming the majority of peers. The industry median Interest Coverage is 4.55. Zhejiang Chemsyn Pharm Co's value of 29.11 is 539.8% above this benchmark. Historically, Zhejiang Chemsyn Pharm Co's own Interest Coverage has ranged from 72.38 to 23,601.75 over the past decade. While the company's 10-year median is 2,041.63 vs. the industry median of 4.55, Zhejiang Chemsyn Pharm Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Healthcare Plans company?
The median Interest Coverage among Healthcare Plans companies is 4.55, based on 15 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zhejiang Chemsyn Pharm Co's current Interest Coverage of 29.11 is 539.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Zhejiang Chemsyn Pharm Co and its competitors. For the Healthcare Plans industry, the median Interest Coverage is 4.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zhejiang Chemsyn Pharm Co's current Interest Coverage is 29.11, which is 99% below median its own 10-year median of 2,041.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhejiang Chemsyn Pharm Co stock overvalued right now?
Zhejiang Chemsyn Pharm Co (BJSE:920656) has a current Interest Coverage of 29.11. The current Interest Coverage is 29.11, which is 99% below median its 10-year median of 2,041.63 and 539.8% above the Healthcare Plans industry median of 4.55. Zhejiang Chemsyn Pharm Co's overall GF Score™ is 36/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Zhejiang Chemsyn Pharm Co (BJSE:920656), the current Interest Coverage is 29.11 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Zhejiang Chemsyn Pharm Co Ltd is engaged in Research, development, production and sales of veterinary drug raw materials, pharmaceutical raw materials and intermediates.
36GF Score
Get the complete analysis for BJSE:920656
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BJSE:920656 has been successfully added to your 
